STING1 and neoplasm: Type I IFNs produced by activation of the cGAS-STING pathway instigate the differentiation and maturation of antigen-presenting cells (APCs) and the expression of MHC molecules, thereby facilitating enhanced tumor antigen presentation (208–211).